The efficacy of hyperbaric oxygen (HBO) therapy was evaluated retrospectively in 43 patients who de veloped symptomatic vasospasm following acute aneurysm surgery. HBO therapy was given as an ad junct to mild hypertensive hypervolemia in 24 patients. Before HBO therapy, 17 patients had no in farct (Group 1), and seven had infarcts (Group 2) caused by vasospasm. A further 19 patients received mild hypertensive hypervolemia alone (Group 3). Cerebral infarcts developed in four Group 1 and 12 Group 3 patients. A good outcome 1 month after surgery was achieved by 13 Group 1 (76%), one Group 2, and seven Group 3 patients (37%). Fifteen of the 24 patients who received HBO therapy responded to HBO exposure, and 12 responding patients (80%) had a good outcome. During HBO ex posure, electroencephalographic improvements were all accompanied by neurological improvements. There were no complications related to HBO therapy. HBO therapy adjunctive to mild hypertensive hypervolemia is helpful in preventing cerebral infarction associated with symptomatic vasospasm.
Introduction
Cerebral vasospasm is probably initiated by ex travasation of red blood cells (RBCs) , but the pathogenesis is not certain. Various agents may pre vent or reverse cerebral vasospasm, but clinical effec tiveness has not been proven. The current trends in therapy for symptomatic vasospasm concentrate on protection against associated ischemic brain damage. Induced hypertension and hypervolemic hemodilu tion are widely used to maintain regional cerebral blood flow (rCBF), but other options should be con sidered to prevent ischemic damage to the brain.
The beneficial effects of hyperbaric oxygen (HBO) therapy have been demonstrated in the management of cerebral ischemia in humans 's,24,25 and in animal experiments .3,s,i9,3o,3s) Cerebral vasospasm has been treated with HBO therapy,") but the relationship be tween the effects of HBO therapy and the severity or duration of neurological deficits caused by vasospasm is not clearly understood.
We reviewed the results of HBO therapy as an ad junct to mild hypertensive hypervolemia after aneurysm surgery, and evaluated the clinical effects.
Patients
and Methods 111 patients treated surgically for ruptured in tracranial aneurysm within 7 days of subarachnoid hemorrhage (SAH) during the 11-year period from June, 1980 through May, 1991 were retrospectively reviewed. Their ages ranged from 19 to 72 years (mean, 56 yrs). Computed tomography (CT) and cerebral angiography (CAG) were performed on ad mission to our hospital. The aneurysms were clipped and as much subarachnoid blood clot as possible evacuated, followed by irrigation of the subarach noid space with lactated Ringer's solution. No bi lateral craniotomy was performed to remove any clot on the contralateral side. All patients were treated postoperatively with a calcium channel blocker or thromboxane A2 synthetase inhibitor to prevent cerebral vasospasm. Symptomatic vaso spasm was diagnosed clinically based on slow onset of confusion and decreased level of consciousness followed by focal cerebral impairment.
Immediately after the diagnosis of symptomatic vasospasm, mild hypervolemic hemodilution was begun if CT revealed no low-density area caused by vasospasm, using colloid agents (fractionate, albumin, low-molecular weight dextran, etc.) in volumes not exceeding 1000 ml/day. Whole blood transfusion was given to anemic patients. The central venous pressure was increased to 7-10 cmH2O, and the hematocrit value reduced and maintained at 35 40%. Simultaneously, the systolic blood pressure was increased slightly using dopamine and/or dobutamine, and maintained at 140-160 mmHg.
Adjunct HBO therapy was given in a multiplace hyperbaric chamber (P-1000SA; Hanyuda, Tokyo) according to the following schedule: 15 minutes of compression with air, 60 minutes of 100% oxygen in halation using an oxygen mask at 2.5 atmospheres ab solute, and 10 minutes of decompression with ox ygen inhalation. HBO therapy was performed once or twice a day for a total of two to 21 cycles (10 cycles on average). Neurological function was evaluated using the Glasgow Coma Scale 14) before, during, and after each HBO cycle. If neurological function improved more than level during or immediately after an HBO exposure, even if transient, the patient was defined as responding to HBO exposure. The outcome 1 month after surgery was assessed using the modified Glasgow Outcome Scale") ( Table 1) . Electroencephalograms (EEGs) were monitored continuously during the first HBO cycle with a 16 channel recorder and EEG power analysis (EEG Trend Monitor;
Nihon-Kohden Ltd., Tokyo) in eight patients. EEG topography was displayed for four patients, the values of % time and amplitude were calculated for each electrode point on the scalp, and compared using the unpaired Student's t-test. (123I-IMP) single photon emission CT (SPECT) revealed decreased rCBF in the territory of the narrowed arteries. Consequently, HBO therapy was begun to prevent ischemia despite the absence of neurological symptoms. Four patients (Cases 1, 7, 8, and 11) showed transient ischemic symptoms after several days, but recovered without neurological deficits or infarcts. The other patient showed no symptoms due to arterial narrowing. Table 4 presents the overall outcome. Fourteen (58%) of 24 patients who received adjunct HBO therapy achieved a good neurological outcome 1 month after surgery. area in the left Sylvian fissure (Fig. IA) . She was classified as Hunt and Hess grade]" III on day 1 of SAH. She underwent surgery for a ruptured aneurysm arising from the left internal carotid artery. Postoperatively, she was slightly confused, and consciousness disturbance increased on day 15. CT scans showed no low-density area, but CAG iden tified arterial narrowing (Fig. 1B) , and 123I-IMP SPECT showed reduced rCBF in the left frontotem poral region (Fig. IC) . Mild hypertensive hyper volemia was given, and HBO therapy started on day 16. Consciousness disturbance decreased during and after the first HBO exposure. EEG during HBO therapy showed an increase in fast components in the background and decreased delta activity (Fig. 2) . The degree of consciousness disturbance fluctuated for a few days after beginning HBO therapy, but other neurological functions were normalized. Case 14: A 53-year-old female presented with a rup tured anterior communicating artery aneurysm. CT scans on admission showed diffuse SAH (Fig. 3A) and she was in Hunt and Hess grade") III. She underwent surgery on day 2 of SAH. She did well until 10 days after SAH, when she became drowsy and developed motor aphasia and right hemipare sis. CAG showed severe arterial narrowing (Fig.  3B ), but CT scans found no low-density area. HBO therapy was given as an adjunct to mild hyperten sive hypervolemia on day 13. Consciousness distur bance and right hemiparesis improved during and after the first HBO exposure. During HBO therapy, EEG showed an increase in fast components in the background and decreased delta activity (Fig. 4) . The neurological improvement was sustained, and she was discharged without deficits. and pulmonary complica tions.2''6'36) We introduced adjunct HBO therapy to prevent ischemic brain tissue and reduce these com plications. Our study shows that the incidence of cerebral infarcts was lower and the outcome was bet ter in patients receiving HBO therapy. In particular, 13 (76%) of 17 patients without infarct before the in itiation of HBO therapy could resume normal life 1 month after surgery. However, HBO therapy was not so effective in patients with infarcts before therapy; this result is similar to that of Kawamura et a1. 's) HBO therapy caused no complications and seems to be safe and effective in preventing cerebral infarction caused by symptomatic vasospasm, although our series of patients was quite small.
Discussion
HBO therapy was also used to prevent symp tomatic vasospasm in five asymptomatic patients with severe arterial narrowing. All made a complete recovery without infarction, although slight tran sient neurological symptoms occurred in four pa tients. HBO therapy can reduce the severity of cerebral vasospasm if initiated before the patient becomes symptomatic.
EEG was used to evaluate brain function under HBO exposure in this study. Clinical improvement is achieved in patients with acute brain damage when EEGs improve during HBO exposure .12,12) EEG im provements are associated with neurological im provements in patients with symptomatic vasospasm.
EEGs and EEG power analysis are useful in evaluating brain function during HBO ex posure.
Our study shows that HBO therapy as an adjunct to hypertensive hypervolemia helps prevent cerebral infarction associated with symptomatic vasospasm, although a further study is required to prove this con clusively. 
